BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Deals

  Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD

  Vitrisa Therapeutics, Inc., today announced that it has entered into an option agreement with Ohr Pharmaceutical for certain rights to the data from the MAKO study

  May 16, 2018

   · 

  2 min read
• FDA

  Additive Orthopaedics Announces FDA Clearance of their Patient Specific 3D Printed Bone Segments for the Global Extremities Market

  Additive Orthopaedics, LLC., today announced that is has received FDA 510(k) clearance for its Patient Specific 3D Printed Bone Segments

  May 16, 2018

   · 

  1 min read
• Drug Development

  CIMZIA® (certolizumab pegol) is the First Therapy to Demonstrate Positive Results in a 52-week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study

  UCB today announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab pegol) on the signs and symptoms of active axSpA in patients without x-ray evidence of ankylosing spondylitis (AS).

  May 16, 2018

   · 

  21 min read
• Biotech Beach

  Pulse Biosciences Grants Equity Incentive Awards to New Employees

  Pulse Biosciences, Inc. today announced granted non-qualified stock options covering an aggregate of 102,000 shares of Pulse Biosciences common stock to three new employees

  May 16, 2018

   · 

  3 min read
• FDA

  FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

  The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride).

  May 16, 2018

   · 

  6 min read
• Business

  Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share

  Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 14.9 cents per share of common stock.

  May 16, 2018

   · 

  1 min read
• Biotech Beach

  NeuroVasc Technologies, Inc. closes Series B financing of $6.3MM

  NeuroVasc Technologies, Inc., announced today that it has closed a $6.3MM Series B Preferred Stock financing.

  May 16, 2018

   · 

  1 min read
• Business

  Genomic Vision Enters Into a Strategic Research Collaboration With Children’s Medical Research Institute (CMRI) on Telomere Length Assay

  Genomic Vision announces the signing of a strategic scientific partnership with Children’s Medical Research Institute (CMRI).

  May 16, 2018

   · 

  4 min read
• 

  How to Use Work-Related Stress to Your Advantage

  Do you have anxiety at work? New study says a little workplace anxiety or stress may help you to be more successful.

  May 16, 2018

   · 

  3 min read
• 

  Business

  Novartis’ Top Attorney Falls on $1.2 Million Sword, Resigns from the Company

  The first Novartis executive has fallen in the wake of the $1.2 million payment to President Donald Trump’s attorney for consulting work.

  May 16, 2018

   · 

  2 min read

   · 

  Alex Keown